About Palobiofarma

Who we are

Palobiofarma S.L is a Spanish biotechnology company founded in 2006 by a group of scientists with experience in drug discovery in several pharmaceutical companies.


The mission of the Palobiofarma is to discover new drugs based on the modulation of adenosine receptors


The Vision of Palobiofarma is to discover the first marketed drug based on a selective adenosine receptor modulator.

How do we achieve our vision

Palobiofarma focused internal resources on areas where lies the experience of the management team::

  • Virtual drug design
  • Medicinal Chemistry
  • In Vitro Pharmacology of adenosine
  • Physico-chemical characterization of the compounds
  • Intellectual Property

The remaining activities needed for the full compound characterization and the nomination of a development candidate, such as the pharmacology and toxicology tests, are carried out through partnerships with various companies (CROs), Research Centres and Universities.